🧫
experiment

In midlife, lower Aβ42:Aβ40 ratio was associated with increased risk of incident all-cause dementia over 6-7 years of follow-up (HR 1.11 per SD lower).

🧫 Experiment Protocol ClinicalAlzheimer's diseasehumanextracted
Plasma biomarkers measured using Quanterix Simoa platform from stored specimens; dementia ascertained by neuropsychological assessment, participant contact, and medical record surveillance
PRIMARY OUTCOME
In midlife, lower Aβ42:Aβ40 ratio was associated with increased risk of incident all-cause dementia over 6-7 years of follow-up (HR 1.11 per SD lower).
LINKED HYPOTHESES
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
amyloid-beta metabolism
MARKET PRICE
$0.50
STATUS
extracted
Prediction Markets (1 direct, 0 via hypothesis — 1 total)
In midlife, lower Aβ42:Aβ40 ratio was associated with increased risk of incident all-causeYES 38% · Liq $100 · cancelled
View on SciDEX ↗